In vitro models to evaluate ingestible devices: Present status and current trends

C O'farrell, K Stamatopoulos, M Simmons… - Advanced Drug Delivery …, 2021 - Elsevier
Orally ingestible medical devices offer significant opportunity in the diagnosis and treatment
of gastrointestinal conditions. Their development necessitates the use of models that …

Lipid-associated oral delivery: Mechanisms and analysis of oral absorption enhancement

O Rezhdo, L Speciner, R Carrier - Journal of Controlled Release, 2016 - Elsevier
The majority of newly discovered oral drugs are poorly water soluble, and co-administration
with lipids has proven effective in significantly enhancing bioavailability of some compounds …

Development of biopredictive dissolution method for extended-release desvenlafaxine tablets

GV Carapeto, MD Duque, MG Issa, HG Ferraz - Pharmaceutics, 2023 - mdpi.com
This study aimed to develop a biopredictive dissolution method for desvenlafaxine ER
tablets using design of experiments (DoE) and physiologically based biopharmaceutics …

Mass Spectrometry Imaging proves differential absorption profiles of well-characterised permeability markers along the crypt-villus axis

A Nilsson, A Peric, M Strimfors, RJA Goodwin… - Scientific reports, 2017 - nature.com
Abstract Knowledge about the region-specific absorption profiles from the gastrointestinal
tract of orally administered drugs is a critical factor guiding dosage form selection in drug …

Electrochemical-induced hydroxylation of aryl halides in the presence of Et 3 N in water

L Yang, Q Zhuang, M Wu, H Long, C Lin… - Organic & Biomolecular …, 2021 - pubs.rsc.org
A thorough study of mild and environmentally friendly electrochemical-induced
hydroxylation of aryl halides without a catalyst is presented. The best protocol consists of …

Physiologically Based Pharmacokinetic Modeling to Unravel the Drug-gene Interactions of Venlafaxine: Based on Activity Score-dependent Metabolism by CYP2D6 …

C Shen, H Yang, W Shao, L Zheng, W Zhang… - Pharmaceutical …, 2024 - Springer
Background Venlafaxine (VEN) is a commonly utilized medication for alleviating depression
and anxiety disorders. The presence of genetic polymorphisms gives rise to considerable …

[HTML][HTML] Hybrid polymeric matrices for oral modified release of Desvenlafaxine succinate tablets

W Samy, A Elnoby, HM El-Gowelli, N Elgindy - Saudi Pharmaceutical …, 2017 - Elsevier
Purpose: Desvenlafaxine succinate (DSV) is a water soluble anti-depressant drug, which is
rapidly absorbed after oral administration exaggerating its side effects. The current work …

In vitro evaluation of absorption characteristics of peramivir for oral delivery

Y Li, Z Wang, X Li, W Gong, X Xie, Y Yang… - European Journal of …, 2017 - Springer
Abstract Background and Objective Peramivir is a novel antiviral agent approved for the
treatment of severe influenza. However, the development of oral formulation of peramivir has …

A novel method to estimate the absorption rate constant for two-compartment model fitted drugs without intravenous pharmacokinetic data

F Liu, H Yi, L Wang, Z Cheng, G Zhang - Frontiers in Pharmacology, 2023 - frontiersin.org
The in vivo performances of most drugs after extravascular administration are fitted well with
the two-compartment pharmacokinetic (PK) model, but the estimation of absorption rate …

In Vitro–In Vivo Correlation for Desvenlafaxine Succinate Monohydrate Extended Release Tablets

JD da Silva, VP de Sousa, LM Cabral, MG Davanço… - AAPS …, 2020 - Springer
The objective of this study was to develop a dissolution test in order to establish an in vitro–
in vivo correlation (IVIVC) model for desvenlafaxine succinate monohydrate (DVSM) …